StockNews.com assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a report issued on Wednesday. The brokerage issued a sell rating on the biopharmaceutical company’s stock.
Galmed Pharmaceuticals Stock Up 10.7 %
Shares of GLMD stock opened at $0.40 on Wednesday. The firm has a market cap of $2.02 million, a price-to-earnings ratio of -0.12 and a beta of 0.87. Galmed Pharmaceuticals has a 12 month low of $0.26 and a 12 month high of $7.80. The stock has a 50-day moving average price of $0.36 and a 200 day moving average price of $0.38.
About Galmed Pharmaceuticals
Featured Stories
- Five stocks we like better than Galmed Pharmaceuticals
- Best Stocks Under $5.00
- High-Yield Texas Instruments Could Hit New Highs Soon
- What is the NASDAQ Stock Exchange?
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- NYSE Stocks Give Investors a Variety of Quality Options
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Galmed Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Galmed Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.